Broad-spectrum antibiotics (ATB) such as carbapenems increase the risk of intestinal GVHD
The carbapenem meropenem exacerbates colonic GvHD in mice via expansion of Bacteroides thetaiotaomicron (BT)
Patients with Intestine GVHD refractory to treatment with glucocorticosteroids, considered the first-line therapy, have a dismal prognosis with survival rates as low as 5%
Currently, there is no standard for second-line therapy for Intestine GVHD
Interestingly, the gastrointestinal (GI) tract plays a vital role in the cytokine release site and the whole process of acute graft-versus-host disease (GVHD ) initiation
Cells that are known to be particularly damaged during the conditioning therapy are Paneth and goblet cells .